Life sciences service providers leverage PAREXEL's eClinical solutions to simplify drug development for customers through technology partnership initiative
PAREXEL International (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced that clinical technology companies CRF Health and Clinical Ink have joined its Perceptive Partner Program. Through the program, technology, consulting, reseller and training companies, as well as contract research organizations (CROs), can enhance and broaden their services to biopharmaceutical customers by leveraging the Perceptive MyTrials eClinical platform along with clinical and technical support services.
Perceptive MyTrials is one of the industry’s leading suites of applications for managing clinical trials. Its flexible, open architecture allows partners to integrate targeted, specialized solutions within the platform. This gives their sponsor customers efficient access to clinical data and applications from a single source, allowing them to more efficiently and effectively manage critical trial activities.
“To better ensure the safety and timeliness of their trials, our customers are increasingly seeking efficient approaches to patient screening, enrollment and randomization,” said Rachael Wyllie, CEO of CRF Health. “As a Perceptive partner, we can address these needs by integrating our electronic Clinical Outcome Assessments [eCOA] offering with Perceptive MyTrials randomization and electronic data capture technologies.”
Ed Seguine, CEO of Clinical Ink, said, “Integrating solutions from Perceptive MyTrials into our SureSource clinical platform will provide sponsors with proven trial management solutions in a user-friendly tablet PC system. This presents a powerful combination of functionality and mobility.”
As study designs become increasingly complex, sponsors are relying on eClinical technologies to manage protocols and evolving regulatory requirements. Developed in 2013 and consisting of an ecosystem of technology and CRO partners, the Perceptive Partner Program offers support services and training that enable service providers to integrate their offerings with individual or collective Perceptive MyTrials applications including:
* DataLabs Electronic Data Capture (EDC)
* ClinPhone Randomization and Trial Supply Management (RTSM)
* IMPACT Clinical Trial Management System (CTMS)
* Electronic Patient Reported Outcomes (ePRO)
* Medical Imaging
* Perceptive MyTrials Data-Driven Monitoring
* LIQUENT Insight Regulatory Information Management
“Sponsors continue to seek fully integrated, best-of-breed technology solutions and clinical outsourcing services that can be efficiently managed,” said Graham Bunn, Vice President, Perceptive Partner Program. “Adding CRF Health and Clinical Ink to our partner program further reinforces its value proposition as the industry’s premier partnership initiative for simplifying drug development.”
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FSP Outsourcing in Clinical Research: Trends and Opportunities
June 9th 2025When drug developers choose the right outsourcing strategies in clinical research, they can gain significant benefits in terms of quality, efficiency, and operational success. In its third annual Functional Service Provider (FSP) Trends Report, Thermo Fisher Scientific’s clinical research business—PPD—gathered insights from 150 global biotech and pharma leaders to determine how FSP models help sponsors address common industry obstacles.